Qube Research & Technologies LTD Icad Inc Call Options Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ICAD
# of Institutions
53Shares Held
5.47MCall Options Held
3.6KPut Options Held
14.6K-
Vanguard Group Inc Valley Forge, PA1.13MShares$2 Million0.0% of portfolio
-
First Eagle Investment Management, LLC675KShares$1.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny601KShares$1.06 Million0.0% of portfolio
-
Black Rock Inc. New York, NY350KShares$619,4520.0% of portfolio
-
Amh Equity LTD296KShares$524,0120.64% of portfolio
About ICAD INC
- Ticker ICAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,333,900
- Market Cap $44.8M
- Description
- iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...